Cancer therapy (Vaxess)

N/A

Report date: 2025/01/26 18:53:06
NME

Base Information

Drug NameCancer therapy (Vaxess)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsSkin NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVaxess Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesVaxess Technologies Inc
Inactive CompaniesN/A
Active IndicationsSkin Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A